Mr. Sigler was formerly a director of ViaCord (now part of PerkinElmer). Mr. Sigler has over 24 years of management experience, including 18 years in the development, manufacturing, and quality management of biological, cell therapy, and small molecule products. As an example, he was divisional head of manufacturing when Genzyme Corporation sought and received regulatory approval for Carticel, an autologous cell therapy product.
Mr. Sigler earned an MBA degree from Harvard Business School and a B.S. degree from Cornell University.
Paul T. Sharpe is the Dickinson Professor of craniofacial biology and the Director of Research at the Dental Institute, King's College London, London, UK. He graduated with a degree in biology from York University (1977) and a Ph.D. degree in biochemistry from Sheffield University, UK (1981). He has published in excess of 200 research papers and supervised over 30 Ph.D. students. Dr. Sharpe is the founder of Odontis, a company developing a biological replacement tooth product. In 2006, Dr. Sharpe's paper "Stem cell-based tissue engineering of teeth" received the William J. Gies Award for best publication in biomaterials and bioengineering from the same organization.
Dr. Paul Krasner, Clinical Professor of Endodontology, received his D.D.S. from Temple University in 1971 and a Certificate in Endodontology from Kingsbrook Jewish Medical Center (New York) in 1975. He completed general practice residencies at Berkshire Medical Center in 1972 and Queens General Hospital/Long Island Jewish Hospital in 1973. Dr. Krasner has been a faculty member of the department since 1977 and is a Diplomate of the American Board of Endodontics. He has a private practice in Pottstown, Pennsylvania.
Dr. Castillo is a Diplomate of the American Board of Pediatric Dentistry. He is the Past-President of the Peruvian Society of Pediatric Dentistry and President of the Peruvian Society of Orthodontics. He is a member of multiple local and international dental associations. Dr. Castillo is a member of the Editorial Board of several indexed international journals. He is professor of the Department of Dentistry for Children and Adolescents at the Universidad Peruana Cayetano Heredia and Affiliate Assistant Professor of the Department of Public Health Sciences at the University of Washington. He has authored several articles published in indexed journals and has lectured in Peru and other countries.
Dr. Ferguson is a consultant to pharmaceutical and life science informatics companies, and federal agencies engaged in or supporting translational biomedical research. He focuses on implementing complete ethical, legal, technical, clinical and informatics solutions for human subjects research involving clinically annotated biospecimens. Prior, he was a founder of Ardais Corporation and co-developed the bioethical and legal frameworks under which the company worked with academic medical centers to bank "human subjects" data and biospecimens that were then distributed to industry and academic researchers.
Dr. Ferguson received his Ph.D. in Molecular Biophysics and Biochemistry from Yale University.
